{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,2,21]],"date-time":"2025-02-21T02:59:10Z","timestamp":1740106750019,"version":"3.37.3"},"reference-count":39,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,5,17]],"date-time":"2025-05-17T00:00:00Z","timestamp":1747440000000},"content-version":"am","delay-in-days":320,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100000026","name":"National Institute on Drug Abuse","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000026","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000060","name":"National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.com.au","clinicalkey.es","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Preventive Medicine"],"published-print":{"date-parts":[[2024,7]]},"DOI":"10.1016\/j.ypmed.2024.108000","type":"journal-article","created":{"date-parts":[[2024,5,10]],"date-time":"2024-05-10T15:17:56Z","timestamp":1715354276000},"page":"108000","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Determinants of receipt of prostate cancer screening among men living with HIV enrolled in an urban HIV Clinic in the United States over the period of 2000\u20132020"],"prefix":"10.1016","volume":"184","author":[{"given":"Filip","family":"Pirsl","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jeanne C.","family":"Keruly","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Richard D.","family":"Moore","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bryan","family":"Lau","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Corinne E.","family":"Joshu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"5","key":"10.1016\/j.ypmed.2024.108000_bb0005","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1086\/605292","article-title":"Primary care guidelines for the management of persons infected with human immunodeficiency virus: 2009 update by the HIV medicine Association of the Infectious Disease Society of America","volume":"49","author":"Alberg","year":"2009","journal-title":"Clin. Infect. Dis."},{"issue":"2","key":"10.1016\/j.ypmed.2024.108000_bb0010","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1093\/jnci\/djr500","article-title":"Prostate cancer screening in the randomized prostate, lung, colorectal, and ovarian Cancer screening trial: mortality results after 13 years of follow-up","volume":"104","author":"Andriole","year":"2012","journal-title":"J. Natl. Cancer Inst."},{"issue":"1","key":"10.1016\/j.ypmed.2024.108000_bb0015","article-title":"Estimated HIV incidence and prevalence in the United States, 2015-2019","volume":"26","author":"Centers for Disease Control and Prevention","year":"2021","journal-title":"HIV Surveillance Supplemental Report"},{"issue":"2","key":"10.1016\/j.ypmed.2024.108000_bb0020","article-title":"Monitoring selected national HIV prevention and care objectives by using HIV surveillance data\u2013United States and 6 dependent areas, 2019","volume":"26","author":"Centers for disease control and prevention","year":"2021","journal-title":"HIV Surveillance Supplemental Report"},{"author":"Centers for Disease Control and Prevention","key":"10.1016\/j.ypmed.2024.108000_bb0025"},{"author":"Centers for Disease Control and Prevention","key":"10.1016\/j.ypmed.2024.108000_bb0030"},{"author":"Clinical Info HIV.gov","key":"10.1016\/j.ypmed.2024.108000_bb0035"},{"author":"Clinical Info HIV.gov","key":"10.1016\/j.ypmed.2024.108000_bb0040"},{"issue":"9","key":"10.1016\/j.ypmed.2024.108000_bb0045","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1093\/jnci\/djy010","article-title":"Risk of breast, prostate, and colorectal Cancer diagnoses among HIV-infected individuals in the United States","volume":"110","author":"Coghill","year":"2018","journal-title":"J. Natl. Cancer Inst."},{"author":"Denning","key":"10.1016\/j.ypmed.2024.108000_bb0050"},{"issue":"4","key":"10.1016\/j.ypmed.2024.108000_bb0055","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1093\/cid\/cix392","article-title":"Cancer-attributable mortality among people with treated human immunodeficiency virus infection in North America","volume":"65","author":"Engels","year":"2017","journal-title":"Clin. Infect. Dis."},{"issue":"7","key":"10.1016\/j.ypmed.2024.108000_bb0060","doi-asserted-by":"crossref","first-page":"1040","DOI":"10.1001\/jamainternmed.2017.0340","article-title":"Recent patterns of prostate-specific antigen testing for prostate Cancer screening in the United States","volume":"177","author":"Fedewa","year":"2017","journal-title":"JAMA Intern. Med."},{"issue":"9","key":"10.1016\/j.ypmed.2024.108000_bb0065","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1007\/s10552-020-01324-x","article-title":"Prostate-specific antigen testing after the US preventive services task force recommendation: a population-based analysis of electronic health data","volume":"31","author":"Frendl","year":"2020","journal-title":"Cancer Causes Control"},{"issue":"2","key":"10.1016\/j.ypmed.2024.108000_bb0070","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1089\/aid.2016.0222","article-title":"Causes of death in HIV-infected individuals with Immunovirologic success in a National Prospective Survey","volume":"33","author":"Goehringer","year":"2017","journal-title":"AIDS Res. Hum. Retrovir."},{"issue":"18","key":"10.1016\/j.ypmed.2024.108000_bb0075","doi-asserted-by":"crossref","first-page":"1901","DOI":"10.1001\/jama.2018.3710","article-title":"Screening for prostate Cancer: US preventive services task force recommendation statement","volume":"319","author":"Grossman DC; U.S. Preventive Services Task Force","year":"2018","journal-title":"JAMA"},{"issue":"6","key":"10.1016\/j.ypmed.2024.108000_bb0080","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1097\/COH.0000000000000578","article-title":"Can the United States achieve 90-90-90?","volume":"14","author":"Hall","year":"2019","journal-title":"Curr. Opin. HIV AIDS"},{"issue":"3","key":"10.1016\/j.ypmed.2024.108000_bb0085","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1007\/s10620-009-0774-8","article-title":"Recent trends for colorectal cancer screening in HIV-infected patients","volume":"55","author":"Iqbal","year":"2010","journal-title":"Dig. Dis. Sci."},{"author":"Kaiser Family Foundation","key":"10.1016\/j.ypmed.2024.108000_bb0090"},{"author":"Kaiser Family Foundation","key":"10.1016\/j.ypmed.2024.108000_bb0095"},{"issue":"3","key":"10.1016\/j.ypmed.2024.108000_bb0100","doi-asserted-by":"crossref","first-page":"E673","DOI":"10.9778\/cmajo.20170038","article-title":"A cross-sectional population-based study of breast cancer screening among women with HIV in Ontario","volume":"5","author":"Kendall","year":"2017","journal-title":"Canada. CMAJ Open."},{"issue":"6","key":"10.1016\/j.ypmed.2024.108000_bb0105","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1093\/jnci\/djaa171","article-title":"Racial and ethnic variation in PSA testing and prostate Cancer incidence following the 2012 USPSTF recommendation","volume":"113","author":"Kensler","year":"2021","journal-title":"J. Natl. Cancer Inst."},{"issue":"2","key":"10.1016\/j.ypmed.2024.108000_bb0110","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1097\/JU.0000000000002249","article-title":"Prostate Cancer screening and incidence among aging persons living with HIV","volume":"207","author":"Leapman","year":"2022","journal-title":"J. Urol."},{"issue":"5","key":"10.1016\/j.ypmed.2024.108000_bb0115","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1097\/QAI.0000000000000202","article-title":"Prostate cancer incidence and prostate-specific antigen testing among HIV-positive and HIV-negative men","volume":"66","author":"Marcus","year":"2014","journal-title":"J. Acquir. Immune Defic. Syndr."},{"key":"10.1016\/j.ypmed.2024.108000_bb0120","doi-asserted-by":"crossref","first-page":"S38","DOI":"10.1097\/00042560-199801001-00011","article-title":"Understanding the clinical and economic outcomes of HIV therapy: the Johns Hopkins HIV clinical practice cohort","volume":"17 Supple 1","author":"Moore","year":"1998","journal-title":"J. Acquir. Immune Defic. Syndr. Hum. Retrovirol."},{"issue":"8","key":"10.1016\/j.ypmed.2024.108000_bb0125","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.1097\/QAD.0000000000000222","article-title":"Causes of death among HIV-infected patients in France in 2010 (national survey): trends since 2000","volume":"28","author":"Morlat","year":"2014","journal-title":"AIDS"},{"issue":"2","key":"10.1016\/j.ypmed.2024.108000_bb0130","doi-asserted-by":"crossref","first-page":"120","DOI":"10.7326\/0003-4819-157-2-201207170-00459","article-title":"Screening for prostate Cancer: U.S. preventive services task force recommendation statement","volume":"157","author":"Moyer VA; U.S. Preventive Services Task Force","year":"2012","journal-title":"Ann. Intern. Med."},{"issue":"3","key":"10.1016\/j.ypmed.2024.108000_bb0135","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1006\/pmed.2001.1003","article-title":"Use of mammographic screening by HIV-infected women in the Women\u2019s interagency HIV study (WIHS)","volume":"34","author":"Preston-Martin","year":"2002","journal-title":"Prev. Med."},{"key":"10.1016\/j.ypmed.2024.108000_bb0140","article-title":"Excess cancers among HIV-infected people in the United States","volume":"107(4):dju503","author":"Robbins","year":"2015","journal-title":"J. Natl. Cancer Inst."},{"issue":"1","key":"10.1016\/j.ypmed.2024.108000_bb0145","doi-asserted-by":"crossref","DOI":"10.1136\/bmjmed-2022-000399","article-title":"Defining the representativeness of study samples in medical and population health research","volume":"2","author":"Rudolph","year":"2023","journal-title":"BMJ Med"},{"issue":"13","key":"10.1016\/j.ypmed.2024.108000_bb0150","doi-asserted-by":"crossref","first-page":"1320","DOI":"10.1056\/NEJMoa0810084","article-title":"Screeening and prostate-cancer mortality in a randomized European study","volume":"360","author":"Schroder","year":"2009","journal-title":"N. Engl. J. Med."},{"issue":"11","key":"10.1016\/j.ypmed.2024.108000_bb0155","doi-asserted-by":"crossref","first-page":"2910","DOI":"10.1158\/1055-9965.EPI-10-0741","article-title":"Reduced risk of prostate cancer in U.S. men with AIDS","volume":"19","author":"Shiels","year":"2010","journal-title":"Cancer Epidemiol. Biomarkers Prev."},{"issue":"12","key":"10.1016\/j.ypmed.2024.108000_bb0160","doi-asserted-by":"crossref","first-page":"866","DOI":"10.7326\/M17-2499","article-title":"Projected Cancer incidence rates and burden of incident Cancer cases in HIV-infected adults in the United States through 2030","volume":"168","author":"Shiels","year":"2018","journal-title":"Ann. Intern. Med."},{"issue":"41","key":"10.1016\/j.ypmed.2024.108000_bb0165","doi-asserted-by":"crossref","first-page":"1473","DOI":"10.15585\/mmwr.mm6941a1","article-title":"Prostate Cancer incidence and survival, by stage and race\/ethnicity \u2013 United States, 2001-2017","volume":"69","author":"Siegel","year":"2020","journal-title":"MMWR Morb Mortal Wkly Repo."},{"issue":"8","key":"10.1016\/j.ypmed.2024.108000_bb0170","doi-asserted-by":"crossref","first-page":"e349","DOI":"10.1016\/S2352-3018(17)30066-8","article-title":"Survival of HIV-positive patients starting antiretroviral therapy between 1996 and 2013: a collaborative analysis of cohort studies","volume":"4","author":"Trickey","year":"2017","journal-title":"Lancet HIV."},{"issue":"3","key":"10.1016\/j.ypmed.2024.108000_bb0175","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1111\/hiv.12412","article-title":"Levels and determinants of breast and cervical cancer screening uptake in HIV-infected women compared with the general population in France","volume":"18","author":"Tron","year":"2017","journal-title":"HIV Med."},{"issue":"4","key":"10.1016\/j.ypmed.2024.108000_bb0180","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1111\/j.1468-1293.2012.01051.x","article-title":"Decreasing mortality and changing patterns of causes of death in the Swiss HIV cohort study","volume":"14","author":"Weber","year":"2013","journal-title":"HIV Med."},{"issue":"2","key":"10.1016\/j.ypmed.2024.108000_bb0185","doi-asserted-by":"crossref","first-page":"70","DOI":"10.3322\/caac.20066","article-title":"American Cancer society guideline for the early detection of prostate cancer: update 2010","volume":"60","author":"Wolf","year":"2010","journal-title":"CA Cancer J. Clin."},{"issue":"8","key":"10.1016\/j.ypmed.2024.108000_bb0190","doi-asserted-by":"crossref","first-page":"1230","DOI":"10.1093\/cid\/cix998","article-title":"Multimorbidity among persons living with human immunodeficiency virus in the United States","volume":"66","author":"Wong","year":"2018","journal-title":"Clin. Infect. Dis."},{"issue":"1","key":"10.1016\/j.ypmed.2024.108000_bb0195","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2021.44027","article-title":"Racial and ethnic disparities in prostate Cancer outcomes in the veterans affairs health care system","volume":"5","author":"Yamoah","year":"2022","journal-title":"JAMA Netw. Open"}],"container-title":["Preventive Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0091743524001555?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0091743524001555?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T04:01:54Z","timestamp":1717214514000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0091743524001555"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,7]]},"references-count":39,"alternative-id":["S0091743524001555"],"URL":"https:\/\/doi.org\/10.1016\/j.ypmed.2024.108000","relation":{},"ISSN":["0091-7435"],"issn-type":[{"type":"print","value":"0091-7435"}],"subject":[],"published":{"date-parts":[[2024,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Determinants of receipt of prostate cancer screening among men living with HIV enrolled in an urban HIV Clinic in the United States over the period of 2000\u20132020","name":"articletitle","label":"Article Title"},{"value":"Preventive Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ypmed.2024.108000","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"108000"}}